Should I Have Adjuvant Immunotherapy? An Interview Study Among Adults with Resected Stage 3 Melanoma and Their Partners
| Title: | Should I Have Adjuvant Immunotherapy? An Interview Study Among Adults with Resected Stage 3 Melanoma and Their Partners |
|---|---|
| Authors: | Ann Livingstone; D Milne; K Dempsey; DM Muscat; AM Menzies; K Howard; MR Stockler; RL Morton |
| Publication Year: | 2021 |
| Subject Terms: | Health Care Sciences & Services; Health Policy & Services; IPILIMUMAB; Life Sciences & Biomedicine; Science & Technology |
| Description: | Should I Have Adjuvant Immunotherapy? An Interview Study Among Adults with Resected Stage 3 Melanoma and Their Partners |
| Document Type: | article in journal/newspaper |
| Language: | unknown |
| Relation: | http://hdl.handle.net/10779/DRO/DU:22735361.v2; https://figshare.com/articles/journal_contribution/Should_I_Have_Adjuvant_Immunotherapy_An_Interview_Study_Among_Adults_with_Resected_Stage_3_Melanoma_and_Their_Partners/22735361 |
| Availability: | http://hdl.handle.net/10779/DRO/DU:22735361.v2; https://figshare.com/articles/journal_contribution/Should_I_Have_Adjuvant_Immunotherapy_An_Interview_Study_Among_Adults_with_Resected_Stage_3_Melanoma_and_Their_Partners/22735361 |
| Rights: | All Rights Reserved |
| Accession Number: | edsbas.560DB64B |
| Database: | BASE |